A Clinical Study of Pterygium and Results of Treatment by Excision and Limbal Autograft or Augmented with Post-Op Mitomycin C


Aim: To prospectively analyze the clinical profile of pterygium and to compare results of management by excision with limbal conjunctival autograft or postoperative topical Mitomycin C drops. Methodology: Study was conducted over a period of 23 months, at a tertiary eye care hospital including 80 eyes of 80 patients who underwent surgery, out of which 40 underwent limbal conjunctival autograft and the remaining 40 underwent pterygium excision followed by Mitomycin C after fulfilling the inclusion criteria. A detailed history was taken and recorded regarding the disease with reference to age, occupation, residence, exposure to dust and hot wind. The extent of corneal involvement by the pterygium was noted. The patients were followed after one week and then monthly for a year. BCVA were noted on every visit and slit lamp examination was done for recurrence, sclera thinning and corneal vascularisation. Result: 80 eyes of 80 patients were enrolled with male preponderance, out of which 40 underwent limbal conjunctival autograft (gr. A) and the remaining 40 underwent pterygium excision followed by Mitomycin C (gr. B). All patients were in the age group of 23 to 70 years. The study showed a higher incidence of pterygium in the age group of 41-50 years with male preponderance probably due to chronic dryness, and exposure to ultraviolet light, dust, and hot winds. The right eye was more affected than the left eye, and nasal side was more involved than the temporal side. The recurrence among group A was 2 out of 40 with a recurrence rate of 5% and among group B was 3 out of 40 with a recurrence rate of 7.5%. Scleral thinning was seen in two cases (5%) in patients who underwent pterygium excision followed by Mitomycin C. Conclusion: Conjunctival limbal autograft and postoperative MMC (0.02%) are both safe and effective adjuncts to primary pterygium surgery. The main prejudices against autografting are the expertise and time required for the procedure. The recent use of biologic adhesives to fixate the autograft in place may simplify the procedure. Age of the patients was strongly associated with recurrence regardless of which procedure was used. More research needs to be done to delve into this seemingly innocuous pathology of conjunctiva to effectively manage the disease condition.

Share and Cite:

Pandey, A. , Marken, N. , Marken, R. and Pandey, B. (2013) A Clinical Study of Pterygium and Results of Treatment by Excision and Limbal Autograft or Augmented with Post-Op Mitomycin C. Open Journal of Ophthalmology, 3, 97-102. doi: 10.4236/ojoph.2013.34023.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] R. M. Youngson, “Pterygium in Israel,” American Journal of Ophthalmology, Vol. 74, No. 5, 1972, pp. 954-959.
[2] R. Detels and S. P. Dhir, “Pterygium: A Geographical Study,” Archives of Ophthalmology, Vol. 78, No. 4, 1967, pp. 485-491.
[3] P. Sivasubramaniam, “Pterygium in Ceylon,” British Journal of Ophthalmology, Vol. 55, 1971, pp. 55-59.
[4] M. S. Norn, “Prevalence of Pinguecula in Greenland and in Copenhagen and Its Relation to Pterygium and Spheroid Degeneration,” Acta Ophthalmologica, Vol. 57, No. 1, 1979, pp. 96-105.
[5] R. T. Rasanayagam, “The Incidence and Racial Distribution of Pterygium in West Malaysia,” Transactions of the Ophthalmological Society of New Zealand, Vol. 25, 1973, pp. 56-59.
[6] J. R. Rojas and H. Malaga, “Pterygium in Lima, Peru,” Annals of Ophthalmology, Vol. 18, No. 4, 1986, pp. 147-149.
[7] A. Meseret, A. Bejiga and M. Ayalew, “Prevalence of Pterygium in Rural Community,” Ethiopian Journal of Health Development, Vol. 22, No. 2, 2008, pp. 191-194.
[8] J. S. Kwon and O. Choi, “A Study of Pterygium in Cheju Island,” Yonsei Medical Journal, Vol. 18, No. 2, 1977, pp. 151-156.
[9] S. Duke Elder, “System of Ophthalmology,” Vol. VIII, Part I, Henry Kimpton, London, 1965, pp. 573-582.
[10] S. K. Rao, T. Lekha, B. N. Mukesh, et al., “Conjunctival-Limbal Autograft for Primary and Recurrent Pterygia,” Indian Journal of Ophthalmology, Vol. 46, No. 4, 1998, pp. 203-209.
[11] J. A. McCoombes, L. W. Hirst and G. P. Isbell, “Sliding Conjuctival Flap for the Treatment of Primary Pterygium,” Ophthalmology, Vol. 101, No. 1, 1994, pp. 169-173.
[12] R. Rachmiel, H. Leiba and S. Levartovsky, “Results of Treatment with Topical Mitomycin C 0.02% Following Excision of Primary Pterygium,” British Journal of Ophthalmology, Vol. 79, No. 3, 1995, pp. 233-236.
[13] J. Shimazaki, H. Y. Yang, K. Tsubota, et al., “Limbal Autograft Transplantation for Recurrent and Advanced Pterygia,” Ophthalmic Surgery Lasers, Vol. 27, No. 11, 1996, pp. 917-923.
[14] R. S. Rubinfeld, R. R. Pfister and R. M. Stein, et al., “Serious Complications of Topical Mitomycin C after Pterygium Surgery,” Ophthalmology, Vol. 99, No. 11, 1992, pp. 1647-1654.
[15] B. D. S. Allan, P. Short, G. J. Crawford, et al., “Pterygium Excision with Conjunctival Autografting: An Effective and Safe Technique,” British Journal of Ophthalmology, Vol. 77, No. 11, 1993, pp. 698-701.
[16] J. A. Cardillo, M. R. Alves, L. E. Ambrosio, et al., “Single Intraoperative Application versus Postoperative Mitomycin C Eye Drops in Pterygium Surgery,” Ophthalmology, Vol. 102, No. 12, 1995, pp. 1949-1952.
[17] P. P. Chen, R. G. Ariyasu, V. Kaza, et al., “A Randomized Trial Comparing Mitomycin C and Conjuctival Autograft after Excision of Primary Pterygium,” American Journal of Ophthalmology, Vol. 120, No. 2, 1995, pp. 151-160.
[18] R. S. Figueiredo, E. J. Cohen, J. A. P. Gomes, et al., “Conjunctival Autograft for Pterygium Surgery: How Well Does It Prevent Recurrence,” Ophthalmic Surgery Lasers, Vol. 28, No. 10, 1997, pp. 99-104.
[19] D. S. C. Lam, A. K. K. Wong and D. S. P. Fan, “Intraoperative Mitomycin C to Prevent Recurrence of Pterygium after Excision. A 30-Month Follow-Up Study,” Ophthalmology, Vol. 105, No. 5, 1998, pp. 901-905.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.